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Abstract
Background: The standard in vitro protocol currently in use for drug testing against Plasmodium
falciparum, based on the incorporation of the purine [3H]-hypoxanthine, has two serious
drawbacks. Firstly it is unsuitable for the testing of drugs that directly or indirectly impact on purine
salvage or metabolism. Secondly, it relies on the use of expensive radiolabelled material, with added
issues concerning detection, storage and waste disposal that make it unsuitable for use in many
disease-endemic areas. Recently, the use of fluorochromes has been suggested as an alternative,
but quenching of the fluorescence signal by the haemoglobin present in cultures of Plasmodium
falciparum-infected erythrocytes severely limits the usefulness of this approach.
Methods:  In order to resolve this problem, a new PicoGreen®-based procedure has been
developed which incorporates additional steps to remove the interfering haemoglobin. The 50%
inhibitory concentration (IC50) values of chloroquine and pyrimethamine against P. falciparum
laboratory lines 3D7 and K1 were determined using the new protocol.
Results: The IC50 values of chloroquine and pyrimethamine against P. falciparum laboratory lines
3D7 and K1 determined with the new fluorescence-based protocol were statistically identical to
those obtained using the traditional 3H-hypoxanthine incorporation method, and consistent with
literature values.
Conclusion: The new method proved to be accurate, reproducible and sensitive, and has the
advantage of being non-radioactive. The improved PicoGreen® method has the potential to replace
traditional in vitro drug resistance assay techniques.
Background
The emergence and spread of Plasmodium falciparum resist-
ant to almost all available antimalarial drugs necessitates
a constant monitoring of parasite susceptibility to antima-
larial drugs, as well as the search for novel chemothera-
peutic agents. Several in vitro drug sensitivity assays exist
for this purpose [1-3]. In vitro drug sensitivity assays are
generally based on culturing P. falciparum isolates in the
presence of a range of antimalarial drug concentrations
for one cycle of intraerythrocytic asexual replication or
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part thereof. The effect of antimalarial drugs is character-
ised by the inhibition of parasite growth. The most widely
accepted test relies on microscopic scoring of parasitized
and uninfected erythrocytes [2]. Other assessment meth-
ods involve the determination of the level of incorpora-
tion of radiolabelled precursors into parasite DNA [1,4]
and colorimetric methods, which involve measurement of
the levels of parasite lactate dehydrogenase (pLDH) [3,5]
or histidine-rich protein II [6]. Each of these commonly-
used assays has unique advantages as well as a number of
known drawbacks. Parasitized cell counts using micro-
scopes are extremely labour-intensive and time-consum-
ing, although they are accurate. Incorporation of
radiolabelled precursors requires supply, storage and dis-
posal of radioactive material, often with a long half-life, as
well as access to scintillation counters, which can be diffi-
cult in some disease-endemic areas where routine moni-
toring of resistance profiles is required. The major
constraints in the use of the colorimetric methods are the
cost and the limited supply of monoclonal antibodies
(mAbs) required.
Recently, a microfluorimetric method using PicoGreen®
for assessing susceptibility of parasites to antiplasmodial
compounds was reported [7]. PicoGreen® (Invitrogen –
Molecular Probes™) is a fluorochrome which selectively
binds double-stranded DNA (dsDNA) by intercalation,
resulting in an exceptionally high increase in fluorescence
emission. PicoGreen® has been shown to detect as little as
25 pg/ml of dsDNA in the presence of single stranded
DNA (ssDNA), RNA, and free nucleotides [7]. Corbett and
co-workers also demonstrated that replication of malaria
parasites was directly proportional to the amount of
PicoGreen®  fluorescence, with a linear relationship
between parasitaemia of 0.1% and 15%.
Although the PicoGreen® method was reported to be suit-
able for high throughput assays, the published method
has an inherent problem, particularly for its use with par-
asite isolates collected from infected individuals with low
parasitaemia in malaria-endemic areas: the possibility of
a serious quenching of fluorescence resulting from the
presence of haemoglobin. PicoGreen® fluorescence occurs
with an excitation maximum at 480 nm and an emission
peak at 520 nm [7], whereas haemoglobin has a wide
absorption spectrum at wavelengths between 300 and
800 nm, with a peak around 450 nm [8]. However, peak
absorption wavelengths are dependent on whether hae-
moglobin is bound to oxygen (oxy-haemoglobin), carbon
monoxide (carboxy-haemoglobin) or neither (deoxy-hae-
moglobin) [8], and the molecule in its degraded form
(met-haemoglobin) also exhibits a different absorption
spectrum [8]. Haemoglobin, therefore, has the potential
to absorb most, if not all, of the fluorescence emitted by
PicoGreen®.
A modified drug sensitivity assay using PicoGreen® has
been developed and tested in order to resolve the problem
of fluorescence quenching. The modified method incor-
porates additional steps to remove contaminating haemo-
globin before analysis of fluorescence. The modified
method has been compared with the traditional [3H]-
hypoxanthine accumulation method in drug sensitivity
assays using chloroquine and pyrimethamine.
Methods
Relationship between DNA concentration and PicoGreen® 
fluorescence
Salmon sperm DNA (Sigma-Aldrich, Poole, UK) was seri-
ally diluted with nucleic acid- and DNase-free water (ICN)
to obtain a range of concentrations from 1,000 ng/ml to 1
ng/ml. One hundred and fifty microlitres of each solution
were dispensed into wells of a white opaque 96-well
microtitre plate (Greiner Bio-One). Fifty microlitres of
lysis/fluorescence-mix, consisting of PicoGreen® (1:200 in
TE buffer, pH 7.5) and Triton X-100 (final concentration,
2%) in nucleic acid- and DNase-free water, were added to
each well. Plates were incubated in the dark at room tem-
perature for between 5–30 minutes and then fluorescence
intensity was measured at 485 nm (excitation) and 528
nm (emission) using a Perkin Elmer LS 55 Luminescence
Spectrophotometer. Control wells consisted of the highest
concentration of salmon sperm DNA solution without
PicoGreen®  or lysis/fluorescence-mix alone in nucleic
acid- and DNase-free water respectively. The mean back-
ground reading from the two control wells was subtracted
from the test fluorescence reading to give the final fluores-
cence measurement. Fluorescence (arbitrary units ranging
from 1 to 1,000 units) was plotted against salmon sperm
DNA concentration. The experiment was repeated in the
absence of Triton X-100. All experiments were performed
in triplicate for three independent experiments.
Effect of haemoglobin on fluorescence readings
Uninfected human blood was washed in RPMI1640
medium to remove most of the white blood cells, and
resuspended in medium to give samples with a haemat-
ocrit range of 1.0% to 5%. Each sample was spiked with
salmon sperm DNA at a fixed concentration of 1,000 ng/
ml. One hundred and fifty microlitres of each mixture
were dispensed into the wells of a white opaque 96-well
microtitre plate. Fifty microlitres of the lysis/fluorescence-
mix were added and the fluorescence signal determined as
described. Fluorescence readings were plotted against hae-
matocrit. Control wells consisted of 150 μl blood at 1.0%
haematocrit but without salmon sperm DNA, and 150 μl
of 1,000 ng/ml salmon sperm DNA solution with no
blood added.Malaria Journal 2006, 5:95 http://www.malariajournal.com/content/5/1/95
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Relationship between parasitaemia and PicoGreen® 
Fluorescence
An in vitro culture of parasite clone 3D7 at 2% haematocrit
was diluted with uninfected erythrocytes (2% haematocrit
in culture medium) to yield samples with parasitaemia
ranging from 0.5% to 15%. One hundred and fifty micro-
litres of each sample were dispensed into each of two
microtitre plates. One set of the plates was processed as
described above, with direct lysis of parasitized erythro-
cytes by the lysis/fluorescence-mix. The other plate was
centrifuged at 600 × g for 10 minutes to pellet the cells.
The supernatant was removed and the cells re-suspended
in saponin (0.15%, w/v in phosphate-buffered saline (1 ×
PBS)) to lyse the erythrocytes and release the malaria par-
asites. The plates were immediately centrifuged at 630 × g
for 10 minutes, and the supernatant was removed. The
pellet was then washed to remove all traces of haemo-
globin by the addition of 200 μl of 1 × PBS to each well
followed by centrifugation at 630 × g. The washing step
was repeated twice to ensure complete removal of haemo-
globin. Finally, following the removal of the supernatant,
pellets were re-suspended in 150 μl of 1 × PBS. Fifty
microlitres of the lysis/fluorescence-mix were added to
each well of the plate and fluorescence signal determined
as described above. Fluorescence reading was plotted
against parasitaemia for each of the two sets of plates.
Drug sensitivity assays with P. falciparum
Two culture-adapted standard laboratory lines of P. falci-
parum, 3D7 and K1, were tested for their sensitivity to
chloroquine and pyrimethamine using the PicoGreen®
assay incorporating the saponin lysis step as described
above. The same drug sensitivity assays were set up in par-
allel using the 3H-hypoxanthine incorporation method.
The two parasite lines selected were known to differ in
their sensitivity to antimalarial drugs: clone 3D7 is sensi-
tive to chloroquine and pyrimethamine [9] whilst K1 is
resistant to both drugs [10]. Parasites were maintained in
continuous culture using standard methods [11]. Cultures
used for the drug sensitivity assay contained predomi-
nantly ring forms of the parasites; in some cases cultures
were naturally synchronous, otherwise they were synchro-
nized by brief incubation with 5% aqueous D-sorbitol
using the standard method [12]. All drug sensitivity assays
were performed in 96-well microtitre plates using the
method described by Rieckmann and others [2,13].
Briefly, stocks of drugs were prepared initially in dimethyl
sulfoxide (DMSO) and then diluted serially with culture
medium (without serum) to achieve the desired concen-
tration range. The final ranges of drug concentrations were
500 nM – 3.8 nM for chloroquine, and 2,000 nM – 15.6
nM for pyrimethamine. Each well of a microtitre plate was
pre-dosed with 50 μl of the appropriate drug solution.
Parasite cultures were diluted with fresh uninfected eryth-
rocytes and RPMI1640 culture medium to achieve a start-
ing parasitaemia of 0.5 – 1.0% and haematocrit of 2%.
Two hundred microlitres of the diluted parasite culture
were added to each well of the pre-dosed plates. Control
wells consisted of 50 μl culture medium without drugs
(but containing the same amount of DMSO as in drug
wells) and 200 μl parasitized or uninfected erythrocytes.
The plates were incubated at 37°C for 42–48 hours in a
modular incubator (FlowLabs), gassed with a mixture of
3% CO2, 1% O2, 96% N2.
Determination of IC50 using the microfluorimetric method
After incubation of parasites as described previously, 150
μl of culture were transferred into a white opaque 96-well
microtitre plate and the plate centrifuged at 600 × g for 10
minutes to pellet the cells. The supernatant was removed
and the cells re-suspended in saponin to lyse the erythro-
cytes, and the pellet washed to remove haemoglobin, as
described above. Following resuspension and addition of
the lysis/fluorescence mix, the plates were incubated at
room temperature in the dark for between 5–30 minutes.
Fluorescence intensity was measured at 485 nm (excita-
tion) and 528 nm (emission) as described previously.
Drug concentration was plotted against corresponding
fluorescence reading and the 50% inhibitory concentra-
tion (IC50) was calculated by non-linear regression using
the Prism software package (GraphPad Software, Inc.).
The 50% inhibitory concentration was defined as the drug
concentration that results in a fluorescence value of
0.5 × (maximum fluorescence - minimum fluorescence)
 (Equation 1).
In this equation the maximum fluorescence is defined by
the no drug control and the minimum fluorescence was
defined by a 100% effective concentration of test drug or
positive control.
Determination of IC50 using the 3H-hypoxanthine uptake 
method
For each test performed using the microfluorescence
method, a second plate was set up for determination of
IC50  values by the [3H]-hypoxanthine incorporation
method. Cultures were plated as described and incubated
at 37°C for an initial period of 24 hours. 10 μl of 1.87 μM
[3H]-hypoxanthine with a specific activity of 37 GBq/
mmol (Amersham Biosciences) were then added to each
well, and the plate was incubated for a further 24 hours.
Cells were harvested from each well onto a fibreglass filter
paper using a Filtermate Harvester (Packard Instruments).
The filter paper was dried, sealed in a plastic bag and 3 ml
scintillation fluid (OptiPhase HiSafe (Perkin Elmer))
added. Radioactivity incorporated into the parasites was
counted with a Microbeta Wallac Trilux liquid scintilla-
tion and luminescence counter. The IC50 values represent-Malaria Journal 2006, 5:95 http://www.malariajournal.com/content/5/1/95
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ing 50% inhibition of uptake of [3H]-hypoxanthine were
determined from a sigmoidal plot of log drug concentra-
tion against radiolabel incorporated into the parasites.
Data analysis
Fifty percent inhibition concentration values were deter-
mined by nonlinear regression analysis of the plot of log-
arithm of concentration against fluorescence reading in
the PicoGreen® assay or against scintillation count (counts
per minute) in the isotopic assay using Graphad PRISM
version 3.02 software. Generally, the IC50 is defined as the
concentration of antimalarial drug producing 50% inhib-
itory effect on parasite viability. Student's t-test was used
to determine the significance of any difference in IC50 val-
ues obtained for each parasite/drug combination using
the PicoGreen® and isotopic method. Mean IC50 values
and standard errors of the mean (s.e.m.) for each drug
were determined from three independent drug sensitivity
assays performed in triplicate on each plate.
Results
Relationship between salmon sperm DNA and 
fluorescence of PicoGreen®
A direct linear relationship was observed between
PicoGreen® fluorescence and salmon sperm DNA concen-
tration (Figure 1). The presence of 2% Triton X-100 in the
fluorescence-mix did not significantly change the slope of
the line (P = 0.481), demonstrating that the fluorescence
signal from the DNA-PicoGreen® adduct was not affected
by the presence of Triton X-100. The fluorescence signal
was significantly reduced when the PicoGreen® was dis-
solved in water instead of the TE buffer (data not shown).
The optimal fluorescence signal was obtained with a
PicoGreen® dilution of 1:200 (v/v) from the stock sup-
plied (Invitrogen).
Effect of haemoglobin on fluorescence reading
PicoGreen®, in the absence of salmon sperm DNA, gave a
background reading of 11.4 arbitrary fluorescence units
(no DNA control). PicoGreen® incubated with salmon
sperm DNA at the high concentration of 1000 ng/ml did
not generate a signal above background when in the pres-
ence of blood with haematocrits ranging from 1 to 5%.
The control well, containing salmon sperm DNA and
PicoGreen®  without haemoglobin, gave a fluorescence
reading of around 400 units.
Relationship between fluorescence of PicoGreen® and 
percent parasitaemia for parasite culture
Following direct lysis of parasitized erythrocytes, only very
low fluorescence of PicoGreen® was detected from wells
containing P. falciparum-infected erythrocytes with hae-
matocrit in the range 0.5 – 5% and parasitaemia ranges up
to 10% parasitaemia (Figure 2). Attempts to solubilise
and precipitate the haemoglobin with a cocktail of 5 parts
of quaternary ammonium hydroxide, 2 parts 30% hydro-
gen peroxide and 2 parts glacial acetic acid [14] could not
reverse the quenching effect of this pigment (data not
shown). Furthermore, varying the emission and excitation
wavelength did not improve the detection of fluorescence
signal.
When haemoglobin was removed through saponin-lysis
and washing, PicoGreen® fluorescence was restored, and a
linear relationship was observed between fluorescence
and percent parasitaemia (Figure 2). The mean fluores-
cent signal obtained following saponin treatment was sig-
nificantly different from that obtained in the untreated
cultures (Student's t-test, P = 0.0009).
Comparison of IC50 values obtained by PicoGreen® method 
or isotopic method
No significant differences in IC50 values for chloroquine
or pyrimethamine were observed between the PicoGreen®
method and isotopic method for either of the two parasite
lines tested (Table 1). Typical graphs showing IC50 values
for chloroquine obtained with either the standard [3H]-
hypoxanthine accumulation assay (Figure 3) or the
improved PicoGreen® method (Figure 4) are presented.
Effect of 2% Triton X-100 on PicoGreen® fluorescence with  salmon sperm DNA Figure 1
Effect of 2% Triton X-100 on PicoGreen® fluores-
cence with salmon sperm DNA. PicoGreen® fluores-
cence with salmon sperm DNA is shown in the presence (❍) 
or absence (■) of 2% Triton X-100. Background fluores-
cence, defined as fluorescence detected in the absence of 
added DNA, was subtracted from each data point. Fluores-
cence is measured as arbitrary units (A.U.). Data shown are 
the mean of 3 independent determinations. Lines were calcu-
lated by linear regression; r2 was >0.99. Analysis of the slope 
in the absence of Triton X-100 indicates that fluorescence 
increases by 3.5 ± 0.07 A.U. for every 10 ng/ml increase in 
DNA concentration.
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Discussion
Reliable and simple methods for the assessment of the
sensitivity of malaria parasites to commonly-used drugs
are important as public health tools, allowing evidence-
based decisions on antimalarial drug policy, as well as for
the evaluation of antiplasmodial activities of new chemo-
therapeutic compounds. Simple, reproducible assays
using fluorescent labels seem to offer advantages over
existing methods, especially for high throughput studies
and for the routine monitoring of drug sensitivity profiles
in malaria-endemic areas.
In preliminary investigations, using a previously pub-
lished method [7], a linear relationship was observed
between fluorescence of PicoGreen® and salmon sperm
DNA concentration, with a clear signal from as little as 1
ng/ml DNA in 1 × PBS. However, the addition of unin-
fected erythrocytes, even at low haematocrit levels, largely
abolished the fluorescence seen with salmon sperm DNA.
Similarly, the fluorescence signal was barely detectable
from cultures of P. falciparum-infected erythrocytes, even
Example of chloroquine responses of P. falciparum lines  obtained with the improved PicoGreen® method Figure 3
Example of chloroquine responses of P. falciparum 
lines obtained with the improved PicoGreen® 
method. A typical sigmoidal graph showing the responses of 
P. falciparum lines 3D7 (■) and K1 (❍) to different concen-
trations of chloroquine obtained with the improved 
PicoGreen® method. Each data point is the mean of two 
wells and the error bars show the standard error of the 
mean.
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Effect of saponin treatment on PicoGreen® fluorescence Figure 2
Effect of saponin treatment on PicoGreen® fluores-
cence. PicoGreen® fluorescence is shown following saponin 
treatment, followed by washing to remove haemoglobin (■), 
or with no saponin treatment (❍), of the parasite culture (1 
– 10% parasitaemia). Background fluorescence was sub-
tracted from each point. Lines were calculated by linear 
regression. The slope of the line for fluorescence in the 
absence of saponin treatment was significantly different from 
zero (P = 0.005; F-test), but was only 1.5% of the slope for 
fluorescence after removal of haemoglobin (87 ± 4 versus 1.3 
± 0.3 A.U./% parasitaemia).
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Table 1: Mean IC50 values for chloroquine and pyrimethamine determined by the PicoGreen® or [3H]-hypoxanthine accumulation 
assay. Mean IC50 values for chloroquine and pyrimethamine were determined by the PicoGreen® or the [3H]-hypoxanthine 
accumulation assay for two laboratory lines of P. falciparum, 3D7 and K1. Data are the means of 3 independent determinations and 
standard error of the mean (s.e.m.) values are given in brackets. P-values were obtained from Student's t-test comparisons of IC50 
values obtained for the two methods.
Parasite Mean IC50 values in nM (s.e.m.)
Drug PicoGreen [3H]-hypoxanthine P-value
3D7
Chloroquine 6.3 (0.4) 7.2 (1.1) 0.47
Pyrimethamine 38.6 (7.6) 47.4 (9.6) 0.51
K1
Chloroquine 141 (29.4) 128 (7.4) 0.69
Pyrimethamine 295 (115.2) 437 (133.4) 0.47Malaria Journal 2006, 5:95 http://www.malariajournal.com/content/5/1/95
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at high levels of parasitaemia. It is likely that this was due
to the quenching of PicoGreen® fluorescence by haemo-
globin, as the emission spectra for PicoGreen® and the
absorption spectra for haemoglobin overlap in the rele-
vant wavelengths. Based on these observations, the pub-
lished method was modified to include removal of the
haemoglobin using saponin lysis of the erythrocyte and
several rounds of washing with PBS. Fluorescence of the
dye was thus restored and a linear relationship between
fluorescence and percent parasitaemia was apparent. This
linearity was reliable between 0.5 – 15% parasitaemia and
was not affected by the synchronicity of the culture (data
not shown).
The technique is not demanding, though caution must be
exercised during the removal of the supernatant after
saponin lysis or during washing with PBS, in order not to
lose any of the freed parasites. The procedure lends itself
well to scaling up and gives clear, accurate and indisputa-
ble results.
Conclusion
Drug sensitivity results (IC50) obtained using the new
method compared well with that of the traditional iso-
topic method for two different drugs and two distinct par-
asite lines. IC50 values were not significantly different for
either assay in either parasite line tested for either chloro-
quine or pyrimethamine. In conclusion, the modified
PicoGreen® method has the potential of replacing the tra-
ditional in vitro drug sensitivity assays.
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